Biogen Inc.
BIIB· Nasdaq
BIIBBiogen Inc.
Filed Feb 15, 2023 · 10-K · 46 days after period end · 0000875045-23-000009
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 |
|---|---|---|---|---|
| Revenue | $2.54B | $2.73B | $2.85B | $3.67B |
| Net Income | $550.40M | $368.20M | $357.90M | $1.44B |
| EPS Diluted | — | — | $2.32 | $8.08 |
Biogen Inc. · CIK 875045 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2022 · filed Feb 15, 2023 · 46 d after period end
